Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01031602 · ClinicalTrials.gov registry record
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
A clinical trial of Gynecologic Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 160
- Enrollment target
- 2
- Study locations
NCT01031602: Completed study of Gynecologic Cancer, sponsored by M.D. Anderson Cancer Center.
NCT01031602 is a study of Gynecologic Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 160 participants, below the 762-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01031602, a study of Gynecologic Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objectives: * Assess the prevalence and severity of depression and anxiety in underserved and minority women seen in the gynecologic oncology clinic at Lyndon Baines Johnson General Hospital. * Assess the prevalence and severity of sexual dysfunction in this patient population.
Conditions Studied
Interventions
- BEHAVIORAL Surveys
Study Locations (2)
Texas
- Lyndon B. Johnson (LBJ) General Hosptial - Houston
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-05 |
What the finished NCT01031602 record still lists
NCT01031602 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 762-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Surveys is the first listed.
NCT01031602 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01031602 about?
NCT01031602 is a clinical study titled "Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients". Objectives: * Assess the prevalence and severity of depression and anxiety in underserved and minority women seen in the gynecologic oncology clinic at Lyndon Baines Johnson General Hospital. * Assess the prevalence and severity of sexual dysfunction in this patient population.
What is the current status of trial NCT01031602?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2007-10. Estimated completion is 2013-05.
What conditions does trial NCT01031602 study?
This clinical trial studies the following conditions: Gynecologic Cancer.
What interventions are being tested in trial NCT01031602?
The interventions under investigation include: Surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT01031602?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01031602 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01031602's enrollment target sits among peer trials
160 13th of 55 higher than 43 of 55 other Gynecologic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gynecologic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
RECRUITING
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia